Back to Browse Journals » Drug Design, Development and Therapy » Volume 2

A safety-modified SV40 Tag developed for human cancer immunotherapy

Authors Stephanie S Tseng-Rogenski, Mohamed S Arredouani, June F Escara-Wilke, Yilin C Neeley, Michael J Imperiale et al

Published 8 January 2008 Volume 2008:2 Pages 17—24

Stephanie S Tseng-Rogenski1, Mohamed S Arredouani2, June F Escara-Wilke1, Yilin C Neeley1, Michael J Imperiale3, Martin G Sanda1,2

1Department of Urology, School of Medicine, University of Michigan, Ann Arbor, MI, USA; 2Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; 3Department of Microbiology and Immunology, School of Medicine, University of Michigan, Ann Arbor, MI, USA

Abstract: Simian virus 40 (SV40)-like DNA sequences have been found in a variety of human tumors, raising the possibility that strategies targeting SV40 may provide a potential avenue for immunotherapy directed against SV40 large T Antigen (Tag)-expressing tumors. We generated a recombinant vaccinia (vac-mTag) expressing mTag and herein assessed the ability of mTag to transform cells and to interact with anti-oncoproteins, as well as screened for the presence of potential HLA-A2.1-restricted epitopes within mTag. We found that transfection of cells with mTag did not lead to their transformation. Also, we demonstrated that mTag protein is degraded rapidly in cells. In addition, our work revealed that mTag did not physically interact with certain anti-oncoproteins. Finally, two potential HLA-A2.1-restricted functional epitopes within mTag sequence were identified. Our results show that mTag lacks the oncogenecity of full-length Tag and harbors potential HLA-A2.1-restricted immunogenic epitopes, hence suggesting the safety of vac-mTag for use in cancer immunotherapy.
Keywords: modified SV-40 T antigen, recombinant vaccinia, cancer immunotherapy

Download Article [PDF] 

Readers of this article also read:

Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis

Tian X, Dai Y, Wang D, Zhang L, Sui C, Meng F, Jiang S, Liu Y, Jiang Y

Drug Design, Development and Therapy 2015, 9:4431-4440

Published Date: 10 August 2015

Differentiating type 1 from type 2 big bubbles in deep anterior lamellar keratoplasty

Dua HS, Katamish T, Said DG, Faraj LA

Clinical Ophthalmology 2015, 9:1155-1157

Published Date: 26 June 2015

Nanoalumina induces apoptosis by impairing antioxidant enzyme systems in human hepatocarcinoma cells

Alarifi S, Ali D, Alkahtani S

International Journal of Nanomedicine 2015, 10:3751-3760

Published Date: 25 May 2015

Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis

Fernández-Villar A, López-Campos JL, Represas Represas C, Marín Barrera L, Leiro Fernández V, López Ramírez C, Casamor R

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:961-967

Published Date: 18 May 2015

Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity

Yuan Q, Han J, Cong WS, Ge Y, Ma DD, Dai ZX, Li YP, Bi XL

International Journal of Nanomedicine 2014, 9:4829-4846

Published Date: 17 October 2014

A multidimensional risk factor model for suicide attempts in later life

Chan SMS, Chiu FKH, Lam CWL, Wong SMC, Conwell Y

Neuropsychiatric Disease and Treatment 2014, 10:1807-1817

Published Date: 18 September 2014

Tinnitus: clinical experience of the psychosomatic connection

Salviati M, Bersani FS, Terlizzi S, Melcore C, Panico R, Romano GF, Valeriani G, Macrì F, Altissimi G, Mazzei F, Testugini V, Latini L, Delle Chiaie R, Biondi M, Cianfrone G

Neuropsychiatric Disease and Treatment 2014, 10:267-275

Published Date: 10 February 2014